KB3022 structure
|
Common Name | KB3022 | ||
|---|---|---|---|---|
| CAS Number | 101001-34-7 | Molecular Weight | 448.53400 | |
| Density | 1.22g/cm3 | Boiling Point | 600.3ºC at 760mmHg | |
| Molecular Formula | C25H24N2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 316.8ºC | |
Use of KB3022KB3022 is a cyclooxygenase (COX) inhibitor. |
| Name | ethyl 2-[2-[4,5-bis(4-methoxyphenyl)-1,3-thiazol-2-yl]pyrrol-1-yl]acetate |
|---|---|
| Synonym | More Synonyms |
| Description | KB3022 is a cyclooxygenase (COX) inhibitor. |
|---|---|
| Related Catalog | |
| Target |
Cyclooxygenase |
| In Vitro | KB3022 (Pamicogrel) is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. KB3022 also has potential in both prophylaxis and treatment of ischemic brain injury[1]. |
| References |
[1]. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42. |
| Density | 1.22g/cm3 |
|---|---|
| Boiling Point | 600.3ºC at 760mmHg |
| Molecular Formula | C25H24N2O4S |
| Molecular Weight | 448.53400 |
| Flash Point | 316.8ºC |
| Exact Mass | 448.14600 |
| PSA | 90.82000 |
| LogP | 5.52590 |
| Vapour Pressure | 2.28E-14mmHg at 25°C |
| Index of Refraction | 1.612 |
| InChIKey | ISCHOARKJADAKJ-UHFFFAOYSA-N |
| SMILES | CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| KB-3022 |
| Ethyl 2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-1H-pyrrole-1-acetate |
| Pamicogrel |
| KBT-3022 |
| 1H-Pyrrole-1-acetic acid,2-(4,5-bis(4-methoxyphenyl)-2-thiazolyl)-,ethyl ester |
| Ethyl 2-(4,5-bis(p-methoxyphenyl)-2-thiazolyl)pyrrole-1-acetate |
| ethyl 2-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]-pyrrole-1-acetate |
| ethyl 2-<4,5-bis(4-methoxyphenyl)thiazole-2-yl>pyrrol-1-yl acetate |
| KB3022 |